Fiasp is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Insulin Aspart.
| Product ID | 0169-3205_0d8112c7-3e31-4272-911f-06e803633178 | 
| NDC | 0169-3205 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Fiasp | 
| Generic Name | Insulin Aspart Injection | 
| Dosage Form | Injection, Solution | 
| Route of Administration | SUBCUTANEOUS | 
| Marketing Start Date | 2018-09-24 | 
| Marketing Category | BLA / NDA | 
| Application Number | BLA208751 | 
| Labeler Name | Novo Nordisk | 
| Substance Name | INSULIN ASPART | 
| Active Ingredient Strength | 100 [iU]/mL | 
| Pharm Classes | Insulin [CS],Insulin Analog [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2021-12-31 | 
| Marketing Start Date | 2019-10-01 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA208751 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2019-10-30 | 
| Marketing Category | NDA | 
| Application Number | NDA208751 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2019-10-01 | 
| Marketing Category | NDA | 
| Application Number | NDA208751 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 2019-10-01 | 
| Marketing Category | NDA | 
| Application Number | NDA208751 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2019-10-30 | 
| Ingredient | Strength | 
|---|---|
| INSULIN ASPART | 100 [iU]/mL | 
| SPL SET ID: | 834e7efc-393f-4c55-9125-628562a8a5cf | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0169-3201 | Fiasp | insulin aspart injection | 
| 0169-3204 | Fiasp | insulin aspart injection | 
| 0169-3205 | Fiasp | insulin aspart injection | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() FIASP  79162960  4966787 Live/Registered  | 
        Novo Nordisk A/S  2015-02-09  | 
![]() FIASP  79140450  4541341 Live/Registered  | 
        Novo Nordisk A/S  2013-10-28  |